TPG Capital Asia Buys Majority Stake In Taiwan-Based Clinical Trials Firm OPC

Login to View

TPG Capital Asia has acquired a majority stake in Taiwan-based clinical trial services provider OPC Holding Company. As part of the transaction, OPC’s founder Jason Chen will transition to the role of chairman. Additional terms of the transaction were not disclosed.

Continue reading with a China Money Network subscription

Join Now

Already have an account or paid subscription? Log in